Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina -ko ikertzaileekin lankidetzan egindako argitalpenak (55)

2024

  1. A new class of polyphenolic carbosilane dendrimers binds human serum albumin in a structure-dependent fashion

    Scientific Reports, Vol. 14, Núm. 1

  2. Cationic Carbosilane Dendrimers for Apmnkq2 Aptamer Transfection in Breast Cancer: An Alternative to Traditional Transfectants.

    Macromolecular Bioscience

  3. Effect of polyphenolic dendrimers on biological and artificial lipid membranes

    Chemistry and Physics of Lipids, Vol. 265

  4. Polyphenolic dendrimers as carriers of anticancer siRNA

    International Journal of Pharmaceutics, Vol. 658

2023

  1. Carbosilane dendritic nanostructures, highly versatile platforms for pharmaceutical applications

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 3

  2. Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study

    International Journal of Pharmaceutics, Vol. 636

  3. Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  4. Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols

    Colloids and Surfaces B: Biointerfaces, Vol. 227

  5. Ruthenium metallodendrimer against triple-negative breast cancer in mice

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 53

2022

  1. Heterofunctional carbosilane polyphenolic dendrons: new antioxidants platforms

    RSC Advances, Vol. 12, Núm. 17, pp. 10280-10288

  2. Heterofunctionalized polyphenolic dendrimers decorated with caffeic acid: Synthesis, characterization and antioxidant activity

    Sustainable Materials and Technologies, Vol. 33

  3. Inhibition of Candida glabrata Biofilm by Combined Effect of Dendritic Compounds and Amphotericin

    Pharmaceutics, Vol. 14, Núm. 8

2021

  1. Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons

    Biomacromolecules, Vol. 22, Núm. 11, pp. 4582-4591

  2. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells

    Dalton Transactions, Vol. 50, Núm. 27, pp. 9500-9511

  3. Effect of the combination of levofloxacin with cationic carbosilane dendron and peptide in the prevention and treatment of staphylococcus aureus biofilms

    Polymers, Vol. 13, Núm. 13

  4. Eradication of candida albicans biofilm viability: In vitro combination therapy of cationic carbosilane dendrons derived from 4-phenylbutyric acid with agno3 and edta

    Journal of Fungi, Vol. 7, Núm. 7

  5. Erratum to: Antioxidant and antibacterial properties of carbosilane dendrimers functionalized with polyphenolic moieties (Pharmaceutics 2020, 12, 698)

    Pharmaceutics

2020

  1. Alkali-Metal Compounds with Bio-Based Ligands as Catalysts for Isoselective Lactide Polymerization: Influence of the Catalyst Aggregation on the Polymerization Control

    Organometallics, Vol. 39, Núm. 12, pp. 2278-2286

  2. Antioxidant and antibacterial properties of carbosilane dendrimers functionalized with polyphenolic moieties

    Pharmaceutics, Vol. 12, Núm. 8, pp. 1-16

  3. CHAPTER 5: Poly(carbosilane) dendrimers and other silicon-containing dendrimers

    Monographs in Supramolecular Chemistry, Vol. 2020-January, Núm. 29, pp. 114-145